MUC1 and breast carcinoma: Our preliminary studies showed that Pt2(4-ethylpyridine)4(berenil)2 (Pt12) used together with anti-MUC1 antibody is more cytotoxic than Pt12 alone or cisplatin with anti-MUC1 in breast cancer MCF-7 and MDA-MB-231 cells.